GlassScriptPhysician profile
Christlaen E Cady
NPI 1275776130
$1,059.62
in general payments reported to CMS, 2019-2025
20 companies · $65.62 in 2025
The $65.62 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $393 · 2022: $272 · 2023: $16.79 · 2024: $312 · 2025: $65.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $139.98 | 2021-2024 | Invega, Invega Sustenna, Risperdal |
| Teva Pharmaceuticals USA, INC. | $139.15 | 2021-2024 | Austedo Xr |
| Lilly USA, LLC | $138.93 | 2021-2022 | |
| Alkermes, INC. | $119.95 | 2024 | Aristada, Aristada Initio |
| Novo Nordisk INC | $83.11 | 2021-2022 | |
| Abbvie INC. | $68.65 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $65.62 | 2025 | Cobenfy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.16 | 2021-2022 | |
| Pfizer INC. | $44.38 | 2021 | |
| Merck Sharp & Dohme LLC | $29.77 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.16 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.69 | 2021 | |
| Ironshore Pharmaceuticals INC. | $20.48 | 2021 | |
| Xeris Pharmaceuticals, INC. | $20.46 | 2021 | |
| Glaxosmithkline, LLC. | $14.93 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.90 | 2021 | |
| Dexcom, INC. | $14.67 | 2022 | |
| Tris Pharma INC | $14.59 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.57 | 2021 | |
| Horizon Therapeutics Plc | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christlaen Cady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.